Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
25 studies found for:    " April 21, 2010":" May 21, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 21, 2010":" May 21, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed DCVax Plus Poly ICLC in Healthy Volunteers
Conditions: HIV-1 Infection;   HIV Infection;   Healthy Volunteers
Interventions: Drug: DCVax-001;   Drug: Poly-ICLC;   Drug: Placebo
2 Completed Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
Conditions: HIV Medication Adherence;   Methamphetamine Use;   Sexual Risk;   Poly-substance Use;   HIV Infections
Interventions: Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training;   Behavioral: Education Attention Control
3 Unknown  Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru
Conditions: HIV;   Adherence;   Sexual Behavior;   HIV Infections
Intervention: Other: Cell phone intervention
4 Recruiting Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women
Conditions: Hazardous Alcohol Use;   Binge Drinking;   High Risk Sexual Behaviors;   HIV Risk Reduction;   HIV Infection
Interventions: Behavioral: Computerized brief alcohol intervention with IVR booster calls;   Behavioral: Computer delivered brief alcohol intervention;   Behavioral: Attention Control
5 Terminated A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
Condition: HIV Infections
Interventions: Biological: Opal-HIV-Gag(c) Low Dose;   Biological: Opal-HIV-Gag(c) Medium dose;   Biological: Opal-HIV-Gag(c) High dose;   Other: Dimethyl Sulfoxide
6 Completed Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)
Conditions: Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.;   Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,;   HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
Intervention:
7 Completed Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda
Condition: HIV Infections
Intervention:
8 Completed A New Telemedicine Approach for Chronic HIV/AIDS Patient Home Care
Condition: HIV Infection
Interventions: Other: Virtual Hospital;   Other: Standard of Care
9 Completed Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study
Conditions: Diarrhea;   HIV Infection
Intervention: Device: LifeStraw Family
10 Completed Reducing Health Problems Associated With Injection Drug Use
Conditions: Intravenous Drug Abuse;   HIV Infections
Interventions: Behavioral: Skin and Needle Hygiene Intervention;   Other: No intervention - assessment-only condition
11 Active, not recruiting Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age
Condition: HIV Infections
Interventions: Drug: AZT-3TC-LPV/r twice a day;   Drug: ABC-3TC-EFV once a day
12 Completed Stonewall Treatment Evaluation Project
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: Stonewall Project
13 Completed Venue-Based Couples CoOp in South Africa
Conditions: Alcoholism;   HIV Infections
Interventions: Behavioral: Couples Intervention;   Behavioral: Women's CoOp;   Behavioral: Women's CoOp and Men's Intervention
14 Unknown  Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: raltegravir (Isentress);   Drug: Truvada®
15 Unknown  Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
Conditions: Opioid-Related Disorders;   Buprenorphine;   HIV;   Cognition;   HIV Infections
Intervention:
16 Terminated The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
17 Active, not recruiting Brief Intervention for Drug Misuse in the Emergency Department
Conditions: Substance Abuse Detection;   HIV;   Hepatitis B;   Hepatitis C;   Brief Intervention;   HIV Infections
Intervention: Behavioral: Brief motivational intervention
18 Completed PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: Atripla®
19 Completed Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Etravirine
20 Active, not recruiting Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV
Condition: HIV Infection
Intervention: Drug: Ziodovudine and Alpha Interferon

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years